Articles
Topic
![](https://www.mabion.eu/wp-content/uploads/2024/07/AdobeStock_730033471-535x535.jpeg)
The benefits of outsourcing your biomanufacturing to a Polish CDMO
Mabion
![](https://www.mabion.eu/wp-content/uploads/2024/07/AdobeStock_709169881-535x535.jpeg)
Four Steps To Identifying The CDMO Proposal Worth Signing
Mabion
![](https://www.mabion.eu/wp-content/uploads/2024/06/AdobeStock_552086339-1-535x535.jpeg)
MALDI-TOF MS techniques in microbial identification
Bioanalytics, Contamination, Microbiology
![Biologics drugs to be approved in 2024.](https://www.mabion.eu/wp-content/uploads/2024/06/AdobeStock_712519504-535x535.jpeg)
Top 5 most expected biologics in 2024
Biologics, Drug development, EMA, FDA, Regulatory
![](https://www.mabion.eu/wp-content/uploads/2024/05/EU-vs-US-535x535.jpg)
Similar but not the same: an in-depth look at the differences between EMA and FDA
Biologics, EMA, FDA, Regulatory
![](https://www.mabion.eu/wp-content/uploads/2024/05/AdobeStock_429545605_Editorial_Use_Only-535x535.jpeg)
A synergy of excellence: Novavax-Mabion partnership during unprecedented times amid the COVID-19 pandemic
Mabion, Vaccines